InflaRx (IFRX) EBITDA (2016 - 2026)

InflaRx has disclosed EBITDA across 11 years of filings, most recently posting -$6.6 million for Q1 2026.

• EBITDA for Q1 2026 came in at -$6.6 million, up 26.27% year-over-year; the trailing twelve-month figure through Mar 2026 was -$53432.9 billion (down 8.69% YoY), and the FY2025 annual result was -$53433.0 billion, down 8.69% from the prior year.
• EBITDA came in at -$6.6 million for Q1 2026 at InflaRx, up from -$53432.9 billion in the prior quarter.
• In the past five years, EBITDA ranged from a high of $16.4 million in Q2 2025 to a low of -$53432.9 billion in Q4 2025.
• The 5-year median for EBITDA is -$14.1 million (2022), against an average of -$9642.2 billion.
• Across the five-year window, EBITDA soared 100.0% in 2022 and plunged 323805866.21% in 2023, its largest moves.
• InflaRx's EBITDA stood at -$14.1 million in 2022, then slumped by 323805866.21% to -$45773.1 billion in 2023, then retreated by 7.4% to -$49161.8 billion in 2024, then declined by 8.69% to -$53432.9 billion in 2025, then soared by 100.0% to -$6.6 million in 2026.
• The last three EBITDA figures came in at -$6.6 million (Q1 2026), -$53432.9 billion (Q4 2025), and -$14.3 million (Q3 2025), per Business Quant data.